Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact email@example.com
SOURCE Research and Markets
DUBLIN, Dec. 21, 2017 /PRNewswire/ --
The "On-Body Subcutaneous Injection Systems" report has been added to Research and Markets' offering.
As new drugs become available for the treatment of an expanding list of health conditions, drug developers have increasingly pursued packaging and delivery options that simplify the administration process and increase the efficiency and reliability with which the drug can be introduced into the patient. For injectable drugs, this pursuit has led to an accelerated evolution in injection device design, creating new opportunities and choices for drug marketers.
As the administration of injectables moves increasingly from practitioner offices and healthcare facilities to patient homes, decisions regarding as-supplied packaging that were once considered boilerplate have moved to the early stages of the development process. A wide spectrum of device attributes, including form factor, device-patient interaction, security and safety, dosing, activation, off-device communication, and drug formulation factors have been incorporated into drug injection devices. Over time, these initiatives will come to be expected by patients in injectable drugs.
What You Will Learn
Key Topics Covered:
1. Executive Summary
2. Subcutaneous Injectable Therapeutics Landscape
3. Device Design Factors
4. On-Body Subcutaneous Device Classes
5. Near-term Product Analysis and Market Data
6. Market Factors
7. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/flj56w/world_onbody?w=5
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/world-on-body-subcutaneous-injection-systems-market-2017-therapeutic-drug-development--drug-delivery-device-evolution--on-body-sc-system-enabling-technologies--device-drug-developer-collaborations-300574356.html
©2017 PR Newswire. All Rights Reserved.